[Rocky Mountain spotted fever in Mexican children: Clinical and mortality factors].

Authors:
  • GÁGerardo Álvarez-Hernández
    Gerardo Álvarez-Hernández
  • MCMaría Del Carmen Candia-Plata
    María Del Carmen Candia-Plata
  • NANatalia Haydeé Acuña-Meléndrez
    Natalia Haydeé Acuña-Meléndrez
  • AVAnabel Patricia Vargas-Ortega
    Anabel Patricia Vargas-Ortega
  • JLJesús David Licona-Enríquez
    Jesús David Licona-Enríquez

  • 1 June 2016
    • journal article
Abstract
Characterize clinical manifestations and predictors of mortality in children hospitalized for spotted fever. Cross-sectional study in 210 subjects with a diagnosis of Rocky Mountain spotted fever (RMSF) in a pediatric hospital in Sonora, from January 1st, 2004 to June 30th, 2015. Data were analyzed using descriptive statistics and multivariate logistic regression. An upward trend was observed in RMSF morbidity and mortality. Fatality rate was 30%.Three predictors were associated with risk of death: delay ≥ 5 days at the start of doxycycline (ORa= 2.95, 95% CI 1.10-7.95), acute renal failure ((ORa= 8.79, 95% CI 3.46-22.33) and severe sepsis (ORa= 3.71, 95% CI 1.44-9.58). RMSF causes high mortality in children, which can be avoided with timely initiation of doxycycline. Acute renal failure and severe sepsis are two independent predictors of death in children with RMSF.